The Global Undescended Testicle Market Will Grow At Highest Pace Owing To Increasing Awareness About Timely Treatment

Ben Stiller

posted on 5 months ago — updated on 2 seconds ago

33
views

The Global Undescended Testicle Market Will Grow At Highest Pace Owing To Increasing Awareness About Timely Treatment

The global undescended testicle market consists of treatment procedures that are used for the management of undescended testicles or cryptorchidism, which is a condition where one or both of the testicles remain undescended within the abdomen or groin region. Undescended testicle is a common birth defect that can occur in babies and young children wherein the testicles fails to move down into the scrotum. If left untreated, it can increase the risk of testicular cancer in later life. The market comprises of drugs, surgical therapies and minimally invasive procedures that are used for management of cryptorchidism. Some common treatment options include hormone therapy using drugs like human chorionic gonadotropin, surgery called orchiopexy to move the testicles into the scrotum and laparoscopic surgery.

The Global Undescended Testicle Market Size Is Estimated To Be Valued At US$ 4.51 Bn In 2024 And Is Expected To Exhibit A CAGR Of 7.3% Over The Forecast Period 2024-2031.

Key Takeaways

Key players operating in the global undescended testicle market are Ferring Pharmaceuticals, Pfizer, Eli Lilly and Company, Sanofi, Merck & Co., Bayer AG, Endo International, AstraZeneca, Johnson & Johnson, Takeda Pharmaceutical. Key players are focused on developing innovative drug delivery systems and minimally invasive surgical procedures to effectively manage undescended testicles.

The global undescended testicle market is witnessing significant growth due to rising prevalence of cryptorchidism worldwide. According to recent studies, around 1-4% of full term babies are affected by undescended testis at birth and about 30% of these retract spontaneously within the first months of life. However, timely diagnosis and treatment is required to address this common birth defect and reduce long term risks.

Technological advancements in surgical procedures such as use of laparoscopy have allowed for improved treatment options compared to traditional open surgeries. Advanced drug delivery mechanisms are also being researched to enhance effectiveness of hormone therapy in early management of undescended testis without the need for surgery in some cases. This is expected to drive overall market growth during the forecast period.

Market Trends

There is an increased adoption of minimally invasive procedures such as laparoscopic orchiopexy for management of cryptorchidism. Compared to traditional open surgery, laparoscopic procedures offer benefits such as less post-operative pain, shorter hospital stay and quicker recovery time. With technological improvements, laparoscopy is becoming the standard of care in pediatric urology.

Another key trend is the development of newer drug formulations with improved bioavailability and effectiveness. Research is ongoing to evaluate safety and efficacy of drug therapies that can delay or potentially eliminate the need for surgical intervention in select cases. This could help address concerns regarding risks of surgery, especially in developing countries.

Market Opportunities

Increasing awareness regarding the risks of leaving undescended testis untreated provides major opportunities for market players to educate parents and physicians globally. Focused initiatives are required in developing regions where lack of clinical resources leads to underdiagnosis and delayed treatment.

There is significant scope for market players to conduct clinical trials on novel drug candidates and combine drug and surgical approaches based on individual patient factors. This could lead to more customized treatment regimens for better management of cryptorchidism.

Impact Of Covid-19 On Global Undescended Testicle Market

The COVID-19 pandemic significantly impacted the global undescended testicle market. During the initial lockdown phase, most non-essential surgeries and procedures got postponed to focus on COVID care. This led to a decline in the number of undescended testicle surgeries performed globally from 2020-2021. Healthcare facilities were overwhelmed treating COVID patients and there was a shortage of hospital staff, surgical beds, and personal protective equipment. Patients and their families were also hesitant to visit hospitals for non-urgent treatments due to the risk of virus exposure.

As restrictions eased from late 2021, the market started recovering gradually. However, there is still a backlog of unperformed surgeries that needs to be cleared. The demand is expected to rise steadily in the coming years. Telemedicine also gained prominence during this period for virtual consultations and follow-ups. This helped provide care to some extent while maintaining social distancing. Future strategies need to focus on minimizing surgical delays, using telehealth for non-invasive treatments, strengthening supply chains and ensuring adequate protective measures in hospitals.

North America And Europe Currently Lead The Market

In terms of value, North America and Europe currently dominate the global undescended testicle market. This is majorly attributed to well-established healthcare systems, higher diagnosis and treatment rates, growing awareness about the condition, and advanced surgical capabilities in countries like the US, Germany, UK and France. Within North America, the US contributes over 60% of the regional market value.

Asia Pacific is expected to be the fastest growing region during the forecast period from 2024-2031. This growth can be attributed to factors like rising healthcare expenditure, increasing medical tourism, large patient population and improving access to healthcare facilities especially in China and India. Awareness campaigns and government initiatives are also helping detect cases early and provide surgically corrective treatments in the region.

What are the key data covered in this Global Undescended Testicle Market report?

:- Market CAGR throughout the predicted period

:- Comprehensive information on the aspects that will drive the Global Undescended Testicle Market's growth between 2024 and 2031.

:- Accurate calculation of the size of the Global Undescended Testicle Market and its contribution to the market, with emphasis on the parent market

:- Realistic forecasts of future trends and changes in consumer behavior

:- Global Undescended Testicle Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa

:- A complete examination of the market's competitive landscape, as well as extensive information on vendors

:- Detailed examination of the factors that will impede the expansion of Global Undescended Testicle Market vendors

FAQ’s

Q.1 What are the main factors influencing the Global Undescended Testicle market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Undescended Testicle Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Undescended Testicle market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?